KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to -$719.0 million.

  • Bausch Health Companies' Cash from Financing Activities fell 28042.33% to -$719.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$422.0 million, marking a year-over-year increase of 5910.85%. This contributed to the annual value of -$868.0 million for FY2024, which is 15884.75% down from last year.
  • As of Q3 2025, Bausch Health Companies' Cash from Financing Activities stood at -$719.0 million, which was down 28042.33% from $358.0 million recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Cash from Financing Activities registered a high of $1.8 billion during Q3 2023, and its lowest value of -$1.2 billion during Q3 2021.
  • Over the past 5 years, Bausch Health Companies' median Cash from Financing Activities value was -$146.0 million (recorded in 2025), while the average stood at -$99.3 million.
  • As far as peak fluctuations go, Bausch Health Companies' Cash from Financing Activities crashed by 88888.89% in 2021, and later skyrocketed by 514444.44% in 2023.
  • Bausch Health Companies' Cash from Financing Activities (Quarter) stood at $275.0 million in 2021, then plummeted by 200.36% to -$276.0 million in 2022, then soared by 71.38% to -$79.0 million in 2023, then surged by 207.59% to $85.0 million in 2024, then tumbled by 945.88% to -$719.0 million in 2025.
  • Its Cash from Financing Activities stands at -$719.0 million for Q3 2025, versus $358.0 million for Q2 2025 and -$146.0 million for Q1 2025.